Agronomics
We invest in opportunities within the Life Science sector, concentrating on, but not limited to, environmentally friendly alternatives to the traditional production of meat and plant-based nutrition sources such as cellular agriculture, cellular aquaculture and the alternative protein space. We focus on investments that provide scalable and commercially viable opportunities.
London, United KingdomFounded 2019
Finance
Coverage
Featured In
Digest
Bunge opens $550M soy plant; EU bars Brazilian meat; cell-cultured products reach pets and courts
Monitor
FDA clears first microbial fermentation-derived animal protein for pet food (prnewswire.com)
Digest
Meatly raises £10.4M for cell-cultured facility; Beyond Meat narrows loss; U.S. meat sales hit $112 billion
Monitor
Meatly raises £10.4M to build Europe's largest cell-cultured meat bioreactor facility (tech.eu)
Digest